China

China's drugmakers face headwinds despite regulatory improvements

Accessibility to innovative medicines is still an issue.

China's drugmakers face headwinds despite regulatory improvements

Accessibility to innovative medicines is still an issue.

China's healthcare industry lures private equity investors

Rising income and a silver population boost demand for medical services.

Chinese healthcare firms are on an IPO frenzy

And foreign players are starting to join in.

Here are the biggest challenges for pharma companies

Pricing pressure plagues even the largest industry players.